ArticleOncotarget2015

Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.

Decai Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.